Pharmacological dissection and distribution of NaN/Nav1.9, T-type Ca2+ currents, and mechanically activated cation currents in different populations of DRG neurons

被引:123
作者
Coste, Bertrand [1 ]
Crest, Marcel [1 ]
Delmas, Patrick [1 ]
机构
[1] CNRS, Lab Neurophysiol Cellulaire, UMR 6150, Fac Med,IFR Jean Roche, F-13916 Marseille 20, France
关键词
D O I
10.1085/jgp.200609665
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Low voltage-activated (LVA) T-type Ca2+ (ICaT) and NaN/Nav1.9 currents regulate DRG neurons by setting the threshold for the action potential. Although alterations in these channels have been implicated in a variety of pathological pain states, their roles in processing sensory information remain poorly understood. Here, we carried out a detailed characterization of LVA currents in DRG neurons by using a method for better separation of NaN/Nav1.9 and ICaT currents. NaN/Nav1.9 was inhibited by inorganic ICa blockers as follows (IC50, mu M): La3+ (46) > Cd2+ (233) > Ni2+ (892) and by mibefradil, a non-dihydropyridine ICaT antagonist. Amiloride, however, a preferential Cav3.2 channel blocker, had no effects on NaN/Nav1.9 current. Using these discriminative tools, we showed that NaN/Nav1.9, Cav3.2, and amiloride- and Ni2+-resistant ICaT (AR-ICaT) contribute differentially to LVA currents in distinct sensory cell populations. NaN/Nav1.9 carried LVA currents into type-I (CI) and type-II (CII) small nociceptors and medium-A delta-like nociceptive cells but not in low-threshold mechanoreceptors, including putative Down-hair (D-hair) and A alpha/beta cells. Cav3.2 predominated in CII-nociceptors and in putative D-hair cells. AR-ICaT was restricted to CII-nociceptors, putative D-hair cells, and A alpha/beta-like cells. These cell types distinguished by their current-signature displayed different types of mechanosensitive channels. CI-and CII-nociceptors displayed amiloride- sensitive high-threshold mechanical currents with slow or no adaptation, respectively. Putative D-hair and A alpha/beta-like cells had low-threshold mechanical currents, which were distinguished by their adapting kinetics and sensitivity to amiloride. Thus, subspecialized DRG cells express specific combinations of LVA and mechanosensitive channels, which are likely to play a key role in shaping responses of DRG neurons transmitting different sensory modalities.
引用
收藏
页码:57 / 77
页数:21
相关论文
共 74 条
[41]   TRPA1 contributes to cold, mechanical, and chemical Nociception but is not essential for hair-cell transduction [J].
Kwan, KY ;
Allchorne, AJ ;
Vollrath, MA ;
Christensen, AP ;
Zhang, DS ;
Woolf, CJ ;
Corey, DP .
NEURON, 2006, 50 (02) :277-289
[42]   Phenotype and function of somatic primary afferent nociceptive neurones with C-, Aδ- or Aα/β-fibres [J].
Lawson, SN .
EXPERIMENTAL PHYSIOLOGY, 2002, 87 (02) :239-244
[43]  
Lee JH, 1999, J NEUROSCI, V19, P1912
[44]   Pharmacological properties of neuronal TTX-resistant sodium channels and the role of a critical serine pore residue [J].
Leffler, A ;
Herzog, RI ;
Dib-Hajj, SD ;
Waxman, SG ;
Cummins, TR .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2005, 451 (03) :454-463
[45]   Mechanosensation and pain [J].
Lewin, GR ;
Moshourab, R .
JOURNAL OF NEUROBIOLOGY, 2004, 61 (01) :30-44
[46]  
Martin RL, 2000, J PHARMACOL EXP THER, V295, P302
[47]   Electrophysiological characterization of the tetrodotoxin-resistant Na+ channel, Nav1.9, in mouse dorsal root ganglion neurons [J].
Maruyama, H ;
Yamamoto, M ;
Matsutomi, T ;
Zheng, TX ;
Nakata, Y ;
Wood, JN ;
Ogata, N .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 449 (01) :76-87
[48]   Mechanical transduction by rat dorsal root ganglion neurons in vitro [J].
McCarter, GC ;
Reichling, DB ;
Levine, JD .
NEUROSCIENCE LETTERS, 1999, 273 (03) :179-182
[49]   The sensory mechanotransduction ion channel ASIC2 (acid sensitive ion channel 2) is regulated by neurotrophin availability [J].
McIlwrath, SL ;
Hu, J ;
Anirudhan, G ;
Shin, JB ;
Lewin, GR .
NEUROSCIENCE, 2005, 131 (02) :499-511
[50]   State-dependent mibefradil block of Na+ channels [J].
McNulty, MM ;
Hanck, DA .
MOLECULAR PHARMACOLOGY, 2004, 66 (06) :1652-1661